TECAR Therapy in the Conservative Management of Stage 2 Lipedema
A randomized controlled Turkish trial from 2025.
TECAR therapy is one of those treatments many women with lipedema hear about sooner or later, whether it comes up in a physiotherapy clinic, during rehab, or through conversations in patient communities. It sounds promising, and it is widely used for pain and swelling in other conditions. But when it comes to lipedema specifically, what does the science actually say, and what is still unknown?
CarinaW first learned she had lipedema 14 years ago and has navigated most of the journey on her own. Today, things look different. We are more connected, and far more knowledge is available than it used to be. CarinaW has a research background and has worked in the lab with both cell studies and DNA-based methods. Now, her passion is to make lipedema knowledge more accessible, which is why she founded the LipedemaScience platform. By subscribing to LipedemaScience, you support the work behind the platform and help make evidence-informed knowledge available to women navigating their lipedema journey.
Join today!
We want to take a closer look at this topic, because it is genuinely interesting and raises important questions about how new treatment methods are tested, interpreted, and sometimes adopted in lipedema care.
